These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 27221205)

  • 1. Standardisation and use of the alcohol biomarker carbohydrate-deficient transferrin (CDT).
    Helander A; Wielders J; Anton R; Arndt T; Bianchi V; Deenmamode J; Jeppsson JO; Whitfield JB; Weykamp C; Schellenberg F;
    Clin Chim Acta; 2016 Aug; 459():19-24. PubMed ID: 27221205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reprint of Standardisation and use of the alcohol biomarker carbohydrate-deficient transferrin (CDT).
    Helander A; Wielders J; Anton R; Arndt T; Bianchi V; Deenmamode J; Jeppsson JO; Whitfield JB; Weykamp C; Schellenberg F;
    Clin Chim Acta; 2017 Apr; 467():15-20. PubMed ID: 28322729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IFCC approved HPLC reference measurement procedure for the alcohol consumption biomarker carbohydrate-deficient transferrin (CDT): Its validation and use.
    Schellenberg F; Wielders J; Anton R; Bianchi V; Deenmamode J; Weykamp C; Whitfield J; Jeppsson JO; Helander A
    Clin Chim Acta; 2017 Feb; 465():91-100. PubMed ID: 28025028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toward standardization of carbohydrate-deficient transferrin (CDT) measurements: II. Performance of a laboratory network running the HPLC candidate reference measurement procedure and evaluation of a candidate reference material.
    Helander A; Wielders JP; Jeppsson JO; Weykamp C; Siebelder C; Anton RF; Schellenberg F; Whitfield JB;
    Clin Chem Lab Med; 2010 Nov; 48(11):1585-92. PubMed ID: 21034250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toward standardization of carbohydrate-deficient transferrin (CDT) measurements: I. Analyte definition and proposal of a candidate reference method.
    Jeppsson JO; Arndt T; Schellenberg F; Wielders JP; Anton RF; Whitfield JB; Helander A;
    Clin Chem Lab Med; 2007; 45(4):558-62. PubMed ID: 17439340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Harmonization of measurement results of the alcohol biomarker carbohydrate-deficient transferrin by use of the toolbox of technical procedures of the International Consortium for Harmonization of Clinical Laboratory Results.
    Weykamp C; Wielders J; Helander A; Anton RF; Bianchi V; Jeppsson JO; Siebelder C; Whitfield JB; Schellenberg F;
    Clin Chem; 2014 Jul; 60(7):945-53. PubMed ID: 24691685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toward standardization of carbohydrate-deficient transferrin (CDT) measurements: III. Performance of native serum and serum spiked with disialotransferrin proves that harmonization of CDT assays is possible.
    Weykamp C; Wielders JP; Helander A; Anton RF; Bianchi V; Jeppsson JO; Siebelder C; Whitfield JB; Schellenberg F;
    Clin Chem Lab Med; 2013 May; 51(5):991-6. PubMed ID: 23241602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of carbohydrate-deficient transferrin in human serum using the Bio-Rad %CDT by HPLC test.
    Helander A; Bergström JP
    Clin Chim Acta; 2006 Sep; 371(1-2):187-90. PubMed ID: 16698004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HPLC and mass spectrometric characterization of a candidate reference material for the alcohol biomarker carbohydrate-deficient transferrin (CDT).
    Oberrauch W; Bergman AC; Helander A
    Clin Chim Acta; 2008 Sep; 395(1-2):142-5. PubMed ID: 18590715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recommendations on the measurement and use of the alcohol consumption biomarker CDT. A position paper from the IFCC Working Group on CDT standardisation.
    Wielders JPM; Porpiglia NM; Schellenberg F; Deenmamode J; Delanghe J; Anton RF; Bortolotti F; Siebelder C; Tagliaro F; Weykamp C; Helander A
    Clin Chim Acta; 2024 Mar; 555():117800. PubMed ID: 38309557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorescent adduct formation with terbium: a novel strategy for transferrin glycoform identification in human body fluids and carbohydrate-deficient transferrin HPLC method validation.
    Sorio D; De Palo EF; Bertaso A; Bortolotti F; Tagliaro F
    Anal Bioanal Chem; 2017 Feb; 409(5):1369-1378. PubMed ID: 27858124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of alcohol use, ethnicity, age, gender, BMI and smoking on the serum transferrin glycoform pattern: implications for use of carbohydrate-deficient transferrin (CDT) as alcohol biomarker.
    Bergström JP; Helander A
    Clin Chim Acta; 2008 Feb; 388(1-2):59-67. PubMed ID: 17980706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation study of Axis-Shield carbohydrate-deficient transferrin (CDT) on ARCHITECT chemistry analyzer.
    Janssen MJ; De Gruyter HL; Stappers PM; Velmans MH; van den Ouweland JM; van Daal H; Hampsink RM
    Clin Chem Lab Med; 2007; 45(11):1555-8. PubMed ID: 17924844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of carbohydrate-deficient transferrin (CDT) in Italy.
    Bianchi V; Arfini C; Helander A
    Clin Chem Lab Med; 2008; 46(12):1759-62. PubMed ID: 19055452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is there an analytical or diagnostic advantage from including trisialo transferrin into the fraction of carbohydrate-deficient transferrin? Lessons from a comparison of two commercial turbidimetric immunoassays with the carbohydrate-deficient transferrin determination by high-performance liquid chromatography.
    Lipkowski M; Dibbelt L; Seyfarth M
    Clin Biochem; 2000 Nov; 33(8):635-41. PubMed ID: 11166010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative HPLC and ELISA studies for CDT isoform characterization in subjects with alcohol related problems. Prospective application in workplace risk-prevention policy.
    Coccini T; Crevani A; Acerbi D; Roda E; Castoldi AF; Crespi V; Manzo L
    G Ital Med Lav Ergon; 2008; 30(2):119-27. PubMed ID: 19068859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HPLC evaluation of clinical and pharmacological factors reported to cause false-positive carbohydrate-deficient transferrin (CDT) levels.
    Bergström JP; Helander A
    Clin Chim Acta; 2008 Mar; 389(1-2):164-6. PubMed ID: 18154729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring of the alcohol biomarkers PEth, CDT and EtG/EtS in an outpatient treatment setting.
    Helander A; Péter O; Zheng Y
    Alcohol Alcohol; 2012; 47(5):552-7. PubMed ID: 22691387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison between serum carbohydrate-deficient transferrin and hair ethyl glucuronide in detecting chronic alcohol consumption in routine.
    Bianchi V; Premaschi S; Raspagni A; Secco S; Vidali M
    Alcohol Alcohol; 2015 May; 50(3):266-70. PubMed ID: 25698630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of transferrin glycation on the use of carbohydrate-deficient transferrin as an alcohol biomarker.
    Helander A; Kenan Modén N
    Alcohol Alcohol; 2013; 48(4):478-82. PubMed ID: 23690231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.